Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-28 @ 1:07 AM
Study NCT ID:
NCT02278458
Status:
UNKNOWN
Last Update Posted:
2015-05-22
First Post:
2014-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer
Sponsor:
Betta Pharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2016-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-10
Completion Date Type:
ESTIMATED
First Submit Date:
2014-10-28
First Submit QC Date:
None
Study First Post Date:
2014-10-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-21
Last Update Post Date:
2015-05-22
Last Update Post Date Type:
ESTIMATED